下载此文档

predictors of availability of long-acting medication for opioid use disorder论文资料.pdf


文档分类:通信/电子 | 页数:约5页 举报非法文档有奖
1/5
下载提示
  • 1.该资料是网友上传的,本站提供全文预览,预览什么样,下载就什么样。
  • 2.下载该文档所得收入归上传者、原创者。
  • 3.下载的文档,不会出现我们的网址水印。
1/5 下载此文档
文档列表 文档介绍
Drug and Alcohol Dependence 204 (2019) 107586
Contents lists available at ScienceDirect
Drug and Alcohol Dependence
journal homepage:
Predictors of availability of long-acting medication for opioid use disorder
T

Chelsea L. Shovera, , Keith Humphreysa,b
a Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Rd. (MC: 5717), Stanford, CA 94305, United States
b Veterans Affairs Palo Alto Health Care System, 3801 Miranda Ave (152-MPD), Palo Alto, CA 94304, United States
ARTICLE INFO ABSTRACT
Keywords: Background: The . Food and Drug Administration has approved three long-acting medications for opioid use
Opioid use disorder disorder (MOUD): extended-release naltrexone (XR-NTX) in 2010, a subdermal buprenorphine implant in 2016,
Naltrexone and a depot buprenorphine injection in 2017. Long-acting MOUD options may improve adherence while re-
B

predictors of availability of long-acting medication for opioid use disorder论文资料 来自淘豆网www.taodocs.com转载请标明出处.

非法内容举报中心
文档信息
  • 页数5
  • 收藏数0 收藏
  • 顶次数0
  • 上传人学习的一点
  • 文件大小191 KB
  • 时间2021-05-21